Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma News

  • Polymorphisms Tied to Bexarotene Side Effects in Cutaneous Lymphoma Screening for APOA5 and APOC3 polymorphisms in patients with cutaneous T-cell lymphoma might help identify those less likely to experience hypertriglyceridemia associated with bexarotene treatment, according to Spanish researchers.
  • Groundskeeper in Bayer U.S. Weed-Killer Case Accepts Reduced Award The school groundskeeper who won a jury trial against Bayer AG's Monsanto unit over allegations that the company's glyphosate-containing weed-killers caused his cancer, accepted a court-mandated reduced punitive damages award on Wednesday.

Non-Hodgkin's Lymphoma Perspective

  • Oncologists' Off-Label Prescribing Pits Access Against Reimbursement Off-label prescribing in oncology is undergoing a change: Payers are more restrictive in their reimbursement for off-label uses, while oncologists are keen to provide access to new immunotherapies.
  • 5 Things to Know About Chronotherapy With the 2017 Nobel Prize in Medicine being awarded to research on circadian rhythms, the time has come to take a look at synchronizing chemotherapy with the body's natural clock. Here are five things you should know about chronotherapy.